Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.

TSX:TH - Post by User

Theratechnologies Inc > Next week

<< Previous

Bullboard Posts

Next >>

Post by Trogarzonon Apr 05, 2024 10:40am

64 Views

Post# 35972651

Next week

Next week:

Monday: AACR... prepare to be amazed or else

Wednesday: Q1... steady Eddy or another unfortunate unexpected non recurring event

If hope is back in Onco and results are Ok... chances of surviving the AGM are better. Otherwise, I fear they dilute us again with the help of IQ for instance to gain the upper hand in votes at our expense. They won't hesitate like usual.

<< Previous

Bullboard Posts

Next >>

Hempalta acquires controlling interest in Hemp Carbon Standard